217 related articles for article (PubMed ID: 22703830)
1. Targeted agents in the third-/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC).
Langer CJ; Mok T; Postmus PE
Cancer Treat Rev; 2013 May; 39(3):252-60. PubMed ID: 22703830
[TBL] [Abstract][Full Text] [Related]
2. Current treatments for advanced stage non-small cell lung cancer.
Stinchcombe TE; Socinski MA
Proc Am Thorac Soc; 2009 Apr; 6(2):233-41. PubMed ID: 19349493
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapies for non-small cell lung cancer.
Dempke WC; Suto T; Reck M
Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic advances in second-line treatment of advanced non-small-cell lung cancer.
Bonomi PD
Clin Lung Cancer; 2004 Nov; 6(3):154-61. PubMed ID: 15555216
[TBL] [Abstract][Full Text] [Related]
5. Clinical evidence for second- and third-line treatment options in advanced non-small cell lung cancer.
de Marinis F; Grossi F
Oncologist; 2008; 13 Suppl 1():14-20. PubMed ID: 18263770
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of the unresectable non small cell lung carcinoma].
Spásová I
Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for advanced stage non-small cell lung cancer.
Fathi AT; Brahmer JR
Semin Thorac Cardiovasc Surg; 2008; 20(3):210-6. PubMed ID: 19038730
[TBL] [Abstract][Full Text] [Related]
9. [Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].
Quoix E
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S113-8. PubMed ID: 18971835
[TBL] [Abstract][Full Text] [Related]
10. Targeted (and chemotherapeutic) agents as maintenance treatment in patients with metastatic non-small-cell lung cancer: current status and future challenges.
Pallis AG; Syrigos K
Cancer Treat Rev; 2012 Nov; 38(7):861-7. PubMed ID: 22217701
[TBL] [Abstract][Full Text] [Related]
11. Extending survival of stage IV non-small cell lung cancer.
Carnio S; Novello S; Mele T; Levra MG; Scagliotti GV
Semin Oncol; 2014 Feb; 41(1):69-92. PubMed ID: 24565582
[TBL] [Abstract][Full Text] [Related]
12. New avenues for second-line treatment of metastatic non-small-cell lung cancer.
Gridelli C; Maione P; Rossi A; Falanga M; Bareschino M; Schettino C; Colantuoni G; Guerriero C; Nicolella D; Rossi E; Ferrara ML; Palazzolo G
Expert Rev Anticancer Ther; 2009 Jan; 9(1):115-24. PubMed ID: 19105711
[TBL] [Abstract][Full Text] [Related]
13. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.
Langer C; Soria JC
Clin Lung Cancer; 2010 Mar; 11(2):82-90. PubMed ID: 20199973
[TBL] [Abstract][Full Text] [Related]
14. ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development.
Scagliotti G; Stahel RA; Rosell R; Thatcher N; Soria JC
Eur J Cancer; 2012 May; 48(7):961-73. PubMed ID: 22397764
[TBL] [Abstract][Full Text] [Related]
15. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents.
Meoni G; Cecere FL; Lucherini E; Di Costanzo F
J Geriatr Oncol; 2013 Jul; 4(3):282-90. PubMed ID: 24070465
[TBL] [Abstract][Full Text] [Related]
16. Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: baseline results of an observational study (FRAME).
Schnabel PA; Smit E; Carpeño Jde C; Leśniewski-Kmak K; Aerts J; Kraaij K; Visseren-Grul C; Dyachkova Y; Taipale K; Girvan A; Moro-Sibilot D
Lung Cancer; 2012 Dec; 78(3):263-9. PubMed ID: 23040326
[TBL] [Abstract][Full Text] [Related]
17. [Second-line treatment and targeted therapy of advanced lung cancer].
Nakamura Y; Yamamoto N
Gan To Kagaku Ryoho; 2009 May; 36(5):710-6. PubMed ID: 19461168
[TBL] [Abstract][Full Text] [Related]
18. The need for third-line treatment in non-small cell lung cancer: an overview of new options.
Syrigos KN; Saif MW; Karapanagiotou EM; Oikonomopoulos G; De Marinis F
Anticancer Res; 2011 Feb; 31(2):649-59. PubMed ID: 21378351
[TBL] [Abstract][Full Text] [Related]
19. The current status of targeted therapy for non-small cell lung cancer.
Francis H; Solomon B
Intern Med J; 2010 Sep; 40(9):611-8. PubMed ID: 20002849
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging medical treatments for non-small cell lung cancer: a primer for pulmonologists.
Mazzone P; Mekhail T
Respir Med; 2012 Apr; 106(4):473-92. PubMed ID: 22119173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
